Health Trials

Ovarian Cancer, Epithelial

3

Review clinical trials related to Ovarian Cancer, Epithelial. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies.

Participants needed: 345
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Nurix Therapeutics, Inc.Updated: Sep 9, 2025Locations: 17
Eligibility criteria

Age ≥ 18 years. [+10]

Active untreated brain metastases. [+30]

Read more
Status: Recruiting

Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer

This project is an open, single-center, prospective study aimed at developing high-sensitivity, high-specificity enrichment SERS chips using femtosecond laser processing technology. It involves extracting information from blood samples of ovarian cancer patients and normal controls, specifically identifying cancer and non-cancer signals. The study will construct a statistical algorithm model for the early diagnosis of ovarian cancer, enabling early identification and intervention for ovarian cancer patients.

Participants needed: 70
Trial details
Age: 18-70Biological sex: FemaleType: ObservationalSponsor: Anhui Provincial HospitalUpdated: Oct 15, 2024Locations: 1
Eligibility criteria

The subjects understand the trial process, sign the informed consent form, volun...

Severe or uncontrolled diseases, including but not limited to: uncontrollable na... [+4]

Read more
Status: Recruiting

Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer

CHIMOVIP is a study to determine the best therapeutic strategy in patient with ovarian advanced cancer.

Participants needed: 84
Trial details
Phase: Phase 2Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Groupe Hospitalier Diaconesses Croix Saint-SimonUpdated: Feb 11, 2021Locations: 7
Eligibility criteria

Histologically confirmed advanced (FIGO stage III or IV) invasive epithelial ova... [+7]

FIGO stage IV extra-abdominal disease, with the exception of lymph nodes and ple... [+7]

Read more